BC
RETA

Brinker Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Brinker Capital’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-985
Closed -$201K – 1008
2019
Q4 		$201K Buy
+985
New +$201K 0.01% 932